We're on a mission to revolutionize arrhythmia care.
LEADERSHIP
For nearly two decades, Rob has served in a variety of roles, leading and advising corporations, nonprofits, institutions of higher education, and state entities. Before being appointed CEO he served as president and chief operating officer at Vektor, where he led clinical, regulatory, engineering, and operations. Rob is a former partner at Vorys, Sater, Seymour and Pease LLP and a former Deputy Solicitor General for the State of Ohio. He had the privilege of clerking for the Honorable R. Guy Cole of the United States Court of Appeals for the Sixth Circuit. Rob earned his JD from Harvard Law School.
Rob Krummen
https://www.linkedin.com/in/kelly-perez-4ab9a41/
Kelly Perez
Dr. Christopher Villongco has over a decade of experience in computational modeling and high-performance computing. He conducted doctoral and post-doctoral research in the Departments of Bioengineering and Medicine at the University of California, San Diego. His work focused on developing and applying patient-specific computational models of cardiac electrophysiology to solve real-world clinical problems, especially heart failure and arrhythmias.
Chris Villongco, Ph.D.
Lana Caron
Michael Andersen
Mihir Naik
Chris Schulte
Emily brings over a decade of marketing experience to the Vektor team, transforming the way companies engage with markets and customers. Prior to joining Vektor, Emily worked for Etsy.com where she had a successful track record leading international marketing, branding initiatives and integrated communications campaigns. Emily has a wealth of experience across multiple fields including FMCG, finance, and technology. She holds a BSc Honors from Loughborough University, UK.
Emily Lovell
Maurice brings over 20 years of legal experience and more than a decade of technical experience to Vektor. His practice focuses on protecting the inventions of companies by analyzing their technologies, developing strategies for protecting their inventions, and implementing those strategies in the U.S. and internationally. Maurice has been responsible for achieving the issuance of over a thousand patents throughout his career. He also advises on infringement, invalidity, litigation, valuation, due diligence, and acquisition issues.
Maurice Pirio
Kate Russ
Patrick Barry, MD
Christian has extensive experience as a machine learning-focused biomedical engineer and researcher. Most recently he was an AI research scientist at the Icahn School of Medicine & the Friedman Brain Institute at Mount Sinai, where he modeled biological data with artificial neural networks and built brain-inspired machine learning algorithms. He earned his Ph.D. in Bioengineering from Imperial College London and his B.A. from Princeton University, and conducted research at the Max-Planck Institute, the Princeton Neuroscience Institute, and the National Institutes of Health (NIH).
Christian Márton Ph.D.
Advisors & board
Dr. David Krummen is a professor of medicine at the University of California San Diego and the director of electrophysiology at the VA San Diego Healthcare System. He is a recognized expert in cardiac arrhythmia research. He pioneered ventricular fibrillation electrical substrate ablation, and has authored over 90 papers in the field.
David Krummen, M.D., FACC, FHRS
Dr. Gordon Ho is an assistant professor of medicine at the University of California San Diego. He has more than 10 years of experience in computational modeling, ventricular fibrillation, and atrial fibrillation. Dr. Ho was recently awarded National Institutes of Health and American Heart Association career development grants to study the mechanisms of atrial fibrillation.
Gordon Ho, M.D., FACC, FHRS
Dr. Andrew McCulloch is Distinguished Professor of Bioengineering and Medicine and the Shu Chien Chancellor's Endowed Chair in Engineering and Medicine at UC San Diego. He is also Director of the Institute of Engineering in Medicine which has 13 centers and over 200 faculty members. His laboratory has pioneered the use of multi-scale computational modeling both for elucidating the molecular mechanisms of heart disease and for patient-specific diagnosis and therapy planning in the clinical management of cardiac arrhythmias, heart failure, and congenital heart diseases.
Andrew McCulloch, Ph.D.
Gery Tomassoni, M.D.
Anish Amin, M.D.
Dr. Birgersdotter-Green is a Professor of Medicine at UCSD and the Director of Pacemaker and ICD Services. She has extensive experience in the design and conduct of clinical trials. Dr. Birgersdotter-Green also serves on the Editorial Review Board for Heart Rhythm and the Journal of the American College of Cardiology.
Ulrika Birgersdotter-Green, M.D.
Benjamin A. D'Souza, M.D.
Dr. Greg Feld is a Professor of Medicine at UCSD and an internationally recognized expert in cardiac electrophysiology. He serves as Director of the Cardiac Electrophysiology Program and Director of the Cardiac Electrophysiology Fellowship Training Program at UCSD.
Greg Feld, M.D.
Dr. John Miller has led the clinical cardiac electrophysiology group at the Indiana University School of Medicine since 1998. He is widely recognized as an expert in catheter and intraoperative mapping and ablation of ventricular tachyarrhythmias. Dr. Miller has authored more than 200 scientific publications and has served on many national committees.
John Miller, M.D., FACC, FAHA, FHRS
Jag Singh, M.D., MSc, D.Phil
Dr. McPherson is a board-certified EP and Clinical Professor of Medicine at Yale. He directed the Cardiology Care Unit and Electrophysiology Service at the VAMC, West Haven, CT from 1983 until 1992, when he moved to Bridgeport Hospital to develop the EP Service there. In 1995, he became the Director of the Cardiology Fellowship Program and is presently the longest serving Cardiology program director in the USA. Dr. McPherson served as chapter President and representative to the ACC Board of Governors from 2020 through 2023.
Craig McPherson, M.D.
Mrs. Janssen has 25+ years of senior leadership experience in the medical technology industry. She led Philips Medical Systems/EPD Solutions as General Manager/Business Leader since 2019. From 2014-2019, Mrs. Janssen served as President of Biotronik Inc. As Vice President at St. Jude Medical she made her mark by leading the charge on multiple industry-first product launches. In her career, she has led teams around the world across commercial, R&D, operations, clinical, marketing, and sales. She is internationally recognized for pioneering and launching industry first innovations.
Marlou Janssen
David Adair
Luc Marengere
Mike is a recognized senior executive with over 20 years of leadership and management experience in the life science, biotech, and diagnostics industries. Mike has built and led successful teams responsible for upwards of $200M in global revenue. Mike co-founded Vektor in 2017 and led the company through development and launch of its first product before moving into his role as executive chairman. Prior to co-founding Vektor, Mike held executive positions at Life Technologies, Serologicals and, most recently, at Sequenom where he played an integral role in the successful sale of its Biosciences division to Telegraph Hill Partners.
Mike Monko
9255 Towne Centre Drive, St 840
San Diego, CA 92121